2022M&A Transaction Multiples
Home Health Multiples - 2022
Sourced from 13 publicly disclosed Home Health acquisitions in 2022. Public records only (SEC EDGAR + verified press releases).
EV / EBITDA
8.2x
median · p25 5.6x - p75 10.9x · n=8
EV / Revenue
1.0x
median · p25 0.7x - p75 1.6x · n=13
Value your Home Health business
Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.
Home Health multiples by year
Other verticals - 2022 multiples
Ambulatory Surgery Center· 6x EBITDAAuto Parts· 8.88x EBITDAConsulting· 13.03x EBITDAConsumer Products· 18.1x EBITDADental Practice· 12.5x EBITDAElectronics· 21.32x EBITDAGaming· 17.91x EBITDAHealthcare IT· 20.5x EBITDAIndustrial Equipment· 13.37x EBITDAIT Services· 6.08x EBITDALaboratory Services· 9.9x EBITDAMedical Devices· 17.03x EBITDAMedical Practice Primary Care· 18.8x EBITDAMedical Practice Specialty· 10.9x EBITDAMental Health· 14x EBITDAOil Gas Services· 7.54x EBITDAOther· 20.2x EBITDAOther Healthcare· 13.4x EBITDAOther Manufacturing· 8.1x EBITDAOther Personal Services· 18.83x EBITDAOther Professional Services· 13.57x EBITDAOther Technology· 19.92x EBITDAPharmacy· 11.02x EBITDAPhysical Therapy· 15x EBITDA
Data sourced from 13 disclosed Home Health M&A transactions in 2022. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →